| In millions, except per share items | Aug-31-23 | Nov-30-22 | Aug-31-22 | May-31-22 | Feb-28-22 | Nov-30-21 | Aug-31-21 | May-31-21 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| Cannabis | | | | | | | | 201.4 |
| Other | | | | 520.1 | 508.5 | | | 311.7 |
| Total revenues | | 602.5 | 613.6 | 628.4 | 617.3 | 589.3 | 563.6 | 513.1 |
| Revenue growth | | 2.2% | 8.9% | 22.5% | 27.4% | | | |
| Cost of goods sold | | 447.0 | 465.4 | 477.9 | 450.1 | 432.0 | 422.0 | 389.9 |
| Gross profit | | 155.5 | 148.2 | 150.5 | 167.2 | 157.3 | 141.7 | 123.2 |
| Gross margin | | 25.8% | 24.2% | 24.0% | 27.1% | 26.7% | 25.1% | 24.0% |
| Selling, general and administrative [+] | | 291.6 | 279.3 | 284.6 | 264.6 | 238.2 | 227.2 | 195.5 |
| Sales and marketing | | 71.8 | 69.9 | 65.9 | 59.1 | 52.3 | 46.3 | 44.1 |
| General and administrative [+] | | 219.9 | 209.4 | 218.7 | 205.5 | 185.9 | 181.0 | 151.4 |
| Wages and related expenses | | 53.0 | 51.0 | 51.7 | 47.6 | 42.4 | 43.1 | 37.1 |
| General and administrative expenses | | 162.0 | 153.8 | 162.8 | 154.2 | 140.3 | 135.1 | 111.6 |
| Research and development | | 0.5 | 0.9 | 1.5 | 1.8 | 1.8 | 1.5 | 0.8 |
| Other operating expenses | | -66.7 | -58.6 | -69.8 | -49.7 | -15.0 | -45.0 | -39.8 |
| EBITDA [+] | | 19.8 | | 2.7 | 17.3 | -3.7 | -7.7 | -0.7 |
| EBITDA growth | | -636.6% | -366.6% | -472.2% | -175.6% | | | |
| EBITDA margin | | 3.3% | 3.3% | 0.4% | 2.8% | -0.6% | -1.4% | -0.1% |
| Depreciation | | 43.7 | | 77.8 | 61.6 | 44.8 | 96.2 | 67.8 |
| EBITA | | -23.9 | -18.0 | -75.1 | -44.2 | -48.5 | -103.9 | -68.6 |
| EBITA margin | | -4.0% | -2.9% | -11.9% | -7.2% | -8.2% | -18.4% | -13.4% |
| Amortization of intangibles | | 101.5 | 110.9 | | 76.8 | 76.8 | | |
| EBIT [+] | | -125.3 | -128.8 | -151.9 | -121.0 | -125.3 | -103.9 | -68.6 |
| EBIT growth | | 0.0% | 24.0% | 121.5% | 73.3% | | | |
| EBIT margin | | -20.8% | -21.0% | -24.2% | -19.6% | -21.3% | -18.4% | -13.4% |
| Non-recurring items [+] | | 434.8 | 435.1 | 460.2 | | 97.3 | 89.2 | 63.6 |
| Restructuring charges | | 5.1 | | | | 31.4 | 24.4 | |
| Legal settlement | | 3.3 | 1.5 | | | 2.3 | 1.2 | |
| Interest expense, net [+] | | 15.4 | 22.2 | 27.9 | 31.9 | 37.5 | 32.4 | 28.0 |
| Interest expense | | 27.1 | 33.9 | 39.7 | 34.8 | 40.4 | 35.3 | 30.9 |
| Interest income | | | | 11.7 | | | | 2.9 |
| Other income (expense), net [+] | | 32.6 | 116.7 | 199.4 | 309.5 | 16.5 | -121.8 | -184.8 |
| Change in fair value of warrants | | -27.8 | -47.9 | -63.9 | -60.0 | -38.9 | -18.8 | -1.2 |
| Pre-tax income | | -542.9 | -469.4 | -440.7 | 59.3 | -243.7 | -347.3 | -345.0 |
| Income taxes | | -10.1 | -4.1 | -6.5 | 2.0 | 10.1 | 1.6 | -9.0 |
| Tax rate | | 1.9% | | 1.5% | | | | 2.6% |
| Minority interest | | 45.1 | 43.3 | 42.7 | 15.6 | 21.2 | 25.9 | 31.4 |
| Net income | | -577.9 | -508.6 | -476.8 | 41.7 | -275.0 | -374.7 | -367.4 |
| Net margin | | -95.9% | -82.9% | -75.9% | 6.8% | -46.7% | -66.5% | -71.6% |
| |
| Basic EPS [+] | | ($1.07) | ($1.02) | ($1.02) | $0.10 | ($0.76) | ($1.22) | ($1.44) |
| Growth | | 40.9% | -16.8% | -29.4% | -104.9% | | | |
| Diluted EPS [+] | | ($1.07) | ($1.01) | ($1.01) | $0.10 | ($0.76) | ($1.22) | ($1.44) |
| Growth | | 40.7% | -16.9% | -29.5% | -104.9% | | | |
| |
| Shares outstanding (basic) [+] | | 538.5 | 500.6 | 469.1 | 416.2 | 361.2 | 307.0 | 255.1 |
| Growth | | 49.1% | 63.1% | 83.9% | 72.2% | | | |
| Shares outstanding (diluted) [+] | | 539.2 | 501.3 | 469.9 | 416.9 | 361.2 | 307.0 | 255.1 |
| Growth | | 49.3% | 63.3% | 84.2% | 72.5% | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |